cancer

Cell Therapeutics Reemerging
Seeking Alpha
Mon, 04/13/09 - 07:35 am
Cell Therapeutics
cancer
Novartis
Opaxio
Zevalin
CuraGen Caught in the Middle
Seeking Alpha
Mon, 04/13/09 - 07:34 am
CuraGen
cancer
Avalon gets warning, hunts for cash
Fierce Biotech
Wed, 04/8/09 - 09:31 am
Avalon
cancer
Experts: Unknown tumor risk for Novo diabetes drug
Yahoo/AP
Fri, 04/3/09 - 07:35 am
cancer
diabetes
Novo Nordisk
liraglutide
Genentech Seals Roche's Dominance of Oncology Market
Seeking Alpha
Wed, 04/1/09 - 09:04 am
Genentech
Roche
buyouts
oncology
cancer
Genzyme acquires rights to three cancer drugs
Marketwatch
Tue, 03/31/09 - 08:25 am
Genzyme
cancer
Bayer
Novartis’s Afinitor May Be ’Mega-Blockbuster,’ Cancer Head Says
Bloomberg
Tue, 03/31/09 - 06:10 am
Novartis
Afinitor
cancer
Seattle Genetics cancer drug to get faster review
Yahoo/AP
Mon, 03/30/09 - 07:12 pm
Seattle Genetics
cancer
Hodgkin's lymphoma
With Spectrum, Zevalin Might Finally Have a Chance
TheStreet.com
Wed, 03/25/09 - 04:12 pm
Spectrum Pharmaceuticals
Zevalin
cancer
Allos Submits Pralatrexate for FDA Approval
TheStreet.com
Wed, 03/25/09 - 04:10 pm
Allos
Pralatrexate
FDA
cancer
Roche reports positive results from gastric cancer study
Pharmaceutical Business Review
Mon, 03/23/09 - 11:16 am
Roche
cancer
Herceptin
OSI Pharma sues Teva and Mylan over Tarceva patent
Yahoo/AP
Fri, 03/20/09 - 11:52 am
OSI Pharmaceuticals
lawsuits
Teva Pharmaceuticals
Mylan
patents
Tarceva
generics
cancer
FDA Accepts IND for Arno Therapeutics' Pan-DAC / Akt Inhibitor, AR-42
Yahoo
Tue, 03/17/09 - 08:33 am
FDA
IND
Arno Therapeutics
cancer
More Than a Few Reasons to Buy CombiMatrix
Seeking Alpha
Fri, 03/13/09 - 08:42 am
CombiMatrix
cancer
biotech
MedImmune returns cancer drug rights to Micromet
Yahoo/AP
Thu, 03/12/09 - 10:26 am
MedImmune
cancer
Micromet
blinatumomab
AstraZeneca
Pfizer shares get boost on cancer drug news
Marketwatch
Thu, 03/12/09 - 10:24 am
Pfizer
cancer
Sutent
pancreatic cancer
Pfizer Cancer Campaign Persuades U.K. to Pay for Drug
Bloomberg
Wed, 03/11/09 - 06:01 am
Pfizer
UK
cancer
Sutent
BioDelivery Sciences: A Bet on FDA Approval
Seeking Alpha
Fri, 03/6/09 - 09:59 am
BioDelivery Sciences
FDA
Onsolis
cancer
Genentech Provokes Doctors’ Ire With Costly Avastin Trial
Bloomberg
Thu, 02/26/09 - 08:01 am
Genentech
Avastin
cancer
Onyx revenue nearly doubles as Nexavar sales rise; results surpass analyst expectations
Yahoo/AP
Tue, 02/24/09 - 06:09 am
ONYX Pharmaceuticals
earnings
cancer
Nexavar

Pages